These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Refractory vasospastic angina causing myocardial infarction and VF arrest requiring combined medical, electrophysiological, percutaneous and surgical intervention--a case report. Nishtar SS; Ali T; Azeem T; Shaukat N; Gershlick A Int J Cardiol; 2007 Jun; 119(1):e4-7. PubMed ID: 17448550 [No Abstract] [Full Text] [Related]
44. [Pharmacology of calcium antagonists]. Klaus W Fortschr Med; 1984 Jul; 102(27-28):728-31. PubMed ID: 6479816 [TBL] [Abstract][Full Text] [Related]
45. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists. Apostolakos MJ; Varon ME New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275 [TBL] [Abstract][Full Text] [Related]
46. Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: A prospective, randomized, double-blind pilot study. Kook H; Hong SJ; Yang KS; Lee S; Kim JS; Park CG PLoS One; 2020; 15(9):e0239039. PubMed ID: 32915892 [TBL] [Abstract][Full Text] [Related]
47. The effects of calcium antagonists after PTCA. Hoberg E Eur Heart J; 1995 Aug; 16 Suppl H():9-12. PubMed ID: 8846803 [TBL] [Abstract][Full Text] [Related]
49. [Reproducibility of spasm in patients with long-term remission of vasospastic angina by medical treatment]. Byun T; Uchida T; Hirosawa K; Mori F; Oomori H; Nagashima M; Enta K; Kodama S; Kasahara S; Iwade K; Hosoda S J Cardiol; 1997 May; 29(5):243-50. PubMed ID: 9174879 [TBL] [Abstract][Full Text] [Related]
50. Coronary artery spasm. Mechanisms and clinical relevance. Braunwald E JAMA; 1981 Oct 23-30; 246(17):1957-9. PubMed ID: 7288977 [No Abstract] [Full Text] [Related]
51. Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker. Schenkat DH; Schulz LT; Johnson BD Ann Pharmacother; 2011 Jul; 45(7-8):e41. PubMed ID: 21693700 [TBL] [Abstract][Full Text] [Related]
52. Pharmacological and therapeutic basis for combined administration of beta blockers and calcium channel blockers in the treatment of stable chronic angina. Spaulding C; Cabanes L; Weber S Br J Clin Pract Suppl; 1997 Apr; 88():17-22. PubMed ID: 9519503 [TBL] [Abstract][Full Text] [Related]
54. Coronary vasoreactivity to ergonovine after angioplasty: difference between the infarct-related coronary artery and the noninfarct-related coronary artery. Yoshitomi Y; Kojima S; Sugi T; Matsumoto Y; Yano M; Kuramochi M Coron Artery Dis; 1998; 9(2-3):105-11. PubMed ID: 9647411 [TBL] [Abstract][Full Text] [Related]
55. Calcium channel blockers. Deedwania PC West J Med; 1982 Jul; 137(1):24-31. PubMed ID: 6291255 [TBL] [Abstract][Full Text] [Related]
57. Relations of platelet Ca2+ handling and membrane microviscosity to vascular tone and restenosis after angioplasty in human coronary artery. Le Feuvre C; Le Quan Sang KH; Brunet A; Catuli D; Metzger JP; Vacheron A; Devynck MA Thromb Haemost; 1998 Apr; 79(4):837-42. PubMed ID: 9569201 [TBL] [Abstract][Full Text] [Related]
58. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
59. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172 [TBL] [Abstract][Full Text] [Related]
60. [The role of spasm in angina pectoris, myocardial infarction and sudden death. Indications for future research and treatment]. Maseri A; Chierchia S; L'Abbate A; Biagini A; Distante A; Parodi O; Brunelli C; Severi S Arch Mal Coeur Vaiss; 1982 Jun; 75(6):701-16. PubMed ID: 6810799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]